Skip to main content
CYH logo

CYH · Community Health Systems Inc · Financials

Track CYH — free
$1.62 +0.01 (+0.62%) At close · Nov 20 Play latest call Q2 2026 earnings call transcript
Market Cap
$228.46M
Shares
141.03M
Volume · Nov 20 2.93M Avg daily vol (3M) 1.65M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$12.49B -1.2%
FY2025 Revenue FY2016–FY2025
Net Income
$509M +198.6%
FY2025 Net Income FY2008–FY2025
Gross Margin
85.07% +0.5pp
FY2025 Gross Margin FY2016–FY2025
Operating Margin
11.92% +7.6pp
FY2025 Operating Margin FY2016–FY2025
Diluted EPS
$3.77 +196.7%
FY2025 Diluted EPS FY2008–FY2025
Operating Cash Flow
$543M +13.1%
FY2025 Operating Cash Flow FY2008–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008
— $11.65B $12.49B $12.63B $12.49B $12.21BG $12.37BG $11.79B $13.21B $14.16B $15.35B $18.44B — — — — — — — —
— $1.7B $1.86B $1.95B $1.99B $1.98B $2.04B $1.96B $2.15B $2.36B $2.67B $3.01B — — — — — — — —
— $9.96B $10.62B $10.69B $10.5B $10.24B $10.33B $9.83B $11.06B $11.8B $12.68B $15.43B — — — — — — — —
— — 85.07% 84.6% 84.04% 83.83% 83.49% 83.35% 83.72% 83.36% 82.6% 83.67% — — — — — — — —
— $436M $426M $486M $505M $534M $540M $558M $608M $700M $861M $1.1B $1.17B $1.19B $783M $726M $657.67M $609.84M $566.54M $506.69M
— — — — — — $3M — — — — — — — — — — — — —
— — — — — — — — — — — — — $17.26B $11.89B $11.61B $10.77B $9.97B $10.68B $9.95B
— $10.39B $11B $12.09B $11.53B $11.39B $10.97B $10.66B $12.56B $13.95B $17.23B $19.3B $18.1B $17.3B $11.9B — — — — —
— $1.27B $1.49B $542M $957M $821M $1.4B $1.13B $650M $208M -$1.88B -$860M $1.34B $1.34B $917M $1.23B $1.13B $1.12B $1.06B $971.88M
— — 11.92% 4.29% 7.66% 6.72% 11.34% 9.55% 4.92% 1.47% -12.23% -4.66% — — — — — — — —
— $1.7B $1.91B $1.03B $1.46B $1.36B $1.94B $1.68B $1.26B $908M -$1.02B $240M $2.51B $2.53B $1.7B $1.95B $1.79B $1.73B $1.63B $1.48B
— — $872M $863M $832M $860M — — — — — — — — $615.15M $622.93M $644.41M $647.59M $643.61M $652.47M
— — $2M $3M $2M $2M $3M $3M $3M $7M $11M $14M $15M $5M $3M $3M $4.65M $1.76M $3.56M $7.06M
— $9M $9M $10M $8M $14M $22M $10M $15M $22M $16M $43M $63M $48M $43M $42M $49.49M $45.44M $36.53M $42.06M
— $412M $724M -$283M $207M $349M $499M $422M -$430M -$715M -$2.83B -$1.72B $411M $342M $346M $522M $473.55M $518.89M $447.66M —
— $223M $48M $79M $191M $170M $131M -$185M $160M -$11M -$449M -$104M $116M $82M $104M $164M $137.65M $163.68M $141.85M $125.27M
— $36M $509M -$516M -$133M $46M $230M $511M -$675M -$788M -$2.46B -$1.72B $158M $92M $141M $266M $201.95M $279.98M $243.15M $218.3M
— — 4.08% -4.08% -1.06% 0.38% 1.86% 4.33% -5.11% -5.57% -16.02% -9.33% — — — — — — — —
— $153M $167M $154M $149M $133M $138M $96M $85M $84M $63M $95M $101M $111M $76M $80M $75.68M $68.46M $63.23M $34.43M
— $22M $510M -$512M -$126M $39M $228M $507M -$674M -$771M -$2.42B -$1.71B $148M $96M $219M $305M $248.4M $270.44M $333.85M $8.88M
USD/shares — $0.28 $3.81 -$3.90 -$1.02 $0.35 $1.82 $4.43 -$5.93 -$6.99 -$22.00 -$15.54 $1.38 $0.82 $1.52 $2.98 $2.24 $3.05 $2.68 $2.34
USD/shares $-0.60 – $0.00 $0.27 $3.77G -$3.90G -$1.02G $0.35G $1.76G $4.39 -$5.93 -$6.99 -$22.00 -$15.54 $1.37 $0.82 $1.51 $2.96 $2.23 $3.01 $2.66 $2.32
shares — — 133.56M 132.1M 130.45M 128.81M 126.75M 115.49M 113.74M 112.73M 111.77M 110.73M 114.45M 111.58M 92.63M 89.24M 89.97M 91.72M 90.61M 93.37M
shares — — 135.01M 132.1M 130.45M 130.06M 130.6M 116.54M 113.74M 112.73M 111.77M 110.73M 115.27M 112.55M 93.82M 89.81M 90.67M 92.95M 91.52M 94.29M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2015: $484.94M in buybacks, $22.54M in dividends.

Debt Profile

Completed filing coverage through Aug 12, 2025

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2026-09-30 USD 4,000,000 10-Q filed 2026-10-29
Current operating lease liabilities 2026-09-30 USD 100,000,000 10-Q filed 2026-10-29
Debt and lease obligations 2026-09-30 USD 9,586,000,000 10-Q filed 2026-10-29
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current long-term debt and lease obligations
USD 18,000,000
Noncurrent debt carrying amount
USD 9,568,000,000
Noncurrent finance lease liabilities 2026-09-30 USD 187,000,000 10-Q filed 2026-10-29
Noncurrent operating lease liabilities 2026-09-30 USD 523,000,000 10-Q filed 2026-10-29
17 filing observations remain unmatched and are excluded from instrument histories.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Some sections could not be verified in 1 agreement document. Other restrictions or tests may apply.

Verified tests, triggers and restrictions appear with each agreement below. A verified term does not establish current compliance.

Loans, facilities and notes

9.750% Senior Secured Notes due 2034

Note · CHS/Community Health Systems, Inc.

Reference: 9.750% Senior Secured Notes due 2034

Active
Original principal
USD 1,790,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Jan 15, 2034

Last reported interest terms: 9.75% Reported 2025-08-12 Later filings may not restate these terms; this does not confirm they still apply.

Verified covenant terms

  • (i) · a Default or an Event of Default shall have occurred and be continuing a Default or an Event of Default shall have occurred and be continuing (or would result immediately thereafter therefrom); Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
    Full wording and supporting evidence
    Source evidence: (i) a Default or an Event of Default shall have occurred and be continuing (or would result immediately thereafter therefrom);
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (17) · Restricted Payments (including loans or advances) in an aggregate amount does not exceed the greater of $375,000,000 and 3.0% of Total Assets Applies to every series under this agreement Metric: aggregate amount Stated threshold: 375000000 $ SECTION 3.3. Limitation on Restricted Payments.
    Full wording and supporting evidence
    Source evidence: (17) Restricted Payments (including loans or advances) in an aggregate amount which, when taken together with all Restricted Payments previously made pursuant to this clause (17), does not exceed the greater of $375,000,000 and 3.0% of Total Assets; *provided, however*, that, at the time of each such Restricted Payment, no Default or Event of Default shall have occurred and be continuing (or result therefrom);
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (18) · the Consolidated Total Leverage Ratio would be no greater than 3.50 to 1.00 the Consolidated Total Leverage Ratio would be no greater than 3.50 to 1.00 Applies to every series under this agreement Metric: Consolidated Total Leverage Ratio Stated threshold: 3.5 to 1.00 SECTION 3.3. Limitation on Restricted Payments.
    Full wording and supporting evidence
    Source evidence: (18) any Restricted Payment made by the Issuer or any Restricted Subsidiary; *provided* that, immediately after giving pro forma effect thereto and the Incurrence of any Indebtedness the net proceeds of which are used to finance such Restricted Payment, the Consolidated Total Leverage Ratio would be no greater than 3.50 to 1.00; and
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (ii) · the Issuer is not able to Incur an additional $1.00 of Indebtedness the Issuer is not able to Incur an additional $1.00 of Indebtedness pursuant to Section 3.2(a) after giving effect, on a pro forma basis, to such Restricted Payment; or Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
    Full wording and supporting evidence
    Source evidence: (ii) the Issuer is not able to Incur an additional $1.00 of Indebtedness pursuant to Section 3.2(a) after giving effect, on a pro forma basis, to such Restricted Payment; or
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (a) · The Issuer shall not, and shall not permit any of its Restricted Subsidiaries The Issuer shall not, and shall not permit any of its Restricted Subsidiaries, directly or indirectly, to: Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries, directly or indirectly, to:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (iii) · the aggregate amount of such Restricted Payment and all other Restricted Payments made since the RP Reference Date would exceed the sum of (without duplication): Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
    Full wording and supporting evidence
    Source evidence: (iii) the aggregate amount of such Restricted Payment and all other Restricted Payments made since the RP Reference Date (and not returned or rescinded) (including Permitted Payments made pursuant to Section 3.3(b)(1) (without duplication), but excluding all other Restricted Payments permitted by Section 3.3(b)) would exceed the sum of (without duplication):
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • SECTION 2.1. · may not issue any Additional Notes the Issuer may not issue any Additional Notes, unless such issuance is in compliance with this Indenture, including Sections 3.2 and 3.6. Applies to every series under this agreement SECTION 2.1. Form, Dating and Terms.
    Full wording and supporting evidence
    Source evidence: Notwithstanding anything to the contrary contained herein, the Issuer may not issue any Additional Notes, unless such issuance is in compliance with this Indenture, including Sections 3.2 and 3.6.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 3.2(a) · Limitation on Indebtedness The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, Incur any Indebtedness (including Acquired Indebtedness) Applies to every series under this agreement Metric: Fixed Charge Coverage Ratio Stated threshold: 2 to 1.00 Testing frequency: on the date of such Incurrence SECTION 3.2. Limitation on Indebtedness.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, Incur any Indebtedness (including Acquired Indebtedness); *provided*, *however*, that the Issuer and any of the Subsidiary Guarantors may Incur Indebtedness (including Acquired Indebtedness), if on the date of such Incurrence and after giving pro forma effect thereto (including pro forma application of the proceeds thereof), the Fixed Charge Coverage Ratio for the Issuer and its Restricted Subsidiaries is greater than 2.00 to 1.00.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 3.19(a) · Holdings and the Issuer shall not, and shall not permit Holdings and the Issuer shall not, and shall not permit any Restricted Subsidiary to, take or knowingly or negligently omit to take, any action Applies to every series under this agreement SECTION 3.19. Impairment of Security Interest.
    Full wording and supporting evidence
    Source evidence: (a) Holdings and the Issuer shall not, and shall not permit any Restricted Subsidiary to, take or knowingly or negligently omit to take, any action which action or omission might reasonably or would (in the good faith determination of the Issuer) have the result of materially impairing the effectiveness of the security interests
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 3.6(a) · Limitation on Liens The Issuer shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create, Incur or permit to exist any Lien Applies to every series under this agreement SECTION 3.6. Limitation on Liens.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create, Incur or permit to exist any Lien (the “Initial Lien”) on any of its assets or properties, in each case whether owned on the Issue Date or thereafter acquired, securing any Indebtedness, other than:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (a) · make any Asset Disposition unless The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, make any Asset Disposition unless: Applies to every series under this agreement SECTION 3.5. Limitation on Sales of Assets and Subsidiary Stock.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, make any Asset Disposition unless:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 3.5(b) · Asset Disposition Offer the Issuer shall within twenty (20) Business Days be required to make an offer Applies to every series under this agreement SECTION 3.5. Limitation on Sales of Assets and Subsidiary Stock.
    Full wording and supporting evidence
    Source evidence: (b) Any Net Available Cash from Asset Dispositions that is not applied or invested or committed to be applied or invested as provided in Section 3.5(a) shall be deemed to constitute “Excess Proceeds” under this Indenture. On the 451st day after an Asset Disposition or the receipt of such Net Available Cash, if the aggregate amount of Excess Proceeds under this Indenture exceeds $200,000,000, the Issuer shall within twenty (20) Business Days be required to make an offer (“Asset Disposition Offer”) to all Holders
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (b) · the Issuer shall within twenty (20) Business Days be required to make an offer the Issuer shall within twenty (20) Business Days be required to make an offer Applies to every series under this agreement Metric: aggregate amount of Excess Proceeds under this Indenture Stated threshold: 200000000 $ SECTION 3.5. Limitation on Sales of Assets and Subsidiary Stock.
    Full wording and supporting evidence
    Source evidence: (b) Any Net Available Cash from Asset Dispositions that is not applied or invested or committed to be applied or invested as provided in Section 3.5(a) shall be deemed to constitute “Excess Proceeds” under this Indenture. On the 451st day after an Asset Disposition or the receipt of such Net Available Cash, if the aggregate amount of Excess Proceeds under this Indenture exceeds $200,000,000, the Issuer shall within twenty (20) Business Days be required to make an offer (“Asset Disposition Offer”) to all Holders and, to the extent the Issuer elects, to the holders of any other outstanding Senior-Priority Obligations (and only to the extent the Excess Proceeds are greater than the outstanding Senior-Priority Obligations, other Senior Indebtedness), to purchase the maximum principal amount of Notes, at an offer price equal to 100% of the principal amount of the Notes, and any such Senior-Priority Obligations (and, if applicable, Senior Indebtedness) to which the Asset Disposition Offer applies that may be purchased out of the Excess Proceeds, in each case, plus accrued and unpaid interest, if any, to, but not including, the date of purchase, in accordance with the procedures set forth in this Indenture or the agreements governing any such Senior-Priority Obligations (and, if applicable, Senior Indebtedness), as applicable, and, with respect to the Notes, in minimum denominations of $2,000 and in integral multiples of $1,000 in excess thereof.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • 8. Repurchase Provisions · Upon certain Asset Dispositions Upon certain Asset Dispositions, the Issuer may be required to use the Excess Proceeds from such Asset Dispositions to offer to purchase the maximum aggregate principal amount of Notes Applies to every series under this agreement 8. Repurchase Provisions
    Full wording and supporting evidence
    Source evidence: Upon certain Asset Dispositions, the Issuer may be required to use the Excess Proceeds from such Asset Dispositions to offer to purchase the maximum aggregate principal amount of Notes and, at the Issuer’s option, Senior-Priority Obligations (and, only to the extent the Excess Proceeds are greater than the outstanding Senior-Priority Obligations, Senior Indebtedness) that may be purchased out of the Excess Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date fixed for the closing of such offer, in accordance with the procedures set forth in Section 3.5 and in Article V of the Indenture.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 4.1(e) · No Guarantor may: No Guarantor may: Applies to every series under this agreement SECTION 4.1. Merger and Consolidation.
    Full wording and supporting evidence
    Source evidence: (e) No Guarantor may:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 4.1(a) · The Issuer will not consolidate with or merge with or into or convey, transfer or lease all or substantially all its assets The Issuer will not consolidate with or merge with or into or convey, transfer or lease all or substantially all its assets, in one or more related transactions, to any Person, unless: Applies to every series under this agreement SECTION 4.1. Merger and Consolidation.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer will not consolidate with or merge with or into or convey, transfer or lease all or substantially all its assets, in one or more related transactions, to any Person, unless:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • 8. Repurchase Provisions · If a Change of Control occurs each Holder will have the right to require the Issuer to repurchase from each Holder all or any part Applies to every series under this agreement Exceptions: unless the Issuer has previously or concurrently delivered a redemption notice with respect to all outstanding Notes pursuant to Section 5.7 of the Indenture that is or has become unconditional 8. Repurchase Provisions
    Full wording and supporting evidence
    Source evidence: If a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with respect to all outstanding Notes pursuant to Section 5.7 of the Indenture that is or has become unconditional, each Holder will have the right to require the Issuer to repurchase from each Holder all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of such Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof plus accrued and unpaid interest, if any, to, but excluding, the date of purchase, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date as provided in, and subject to the terms of, the Indenture.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 3.9(a) · If a Change of Control occurs the Issuer shall make an offer to purchase all of the Notes pursuant to the offer described below Applies to every series under this agreement Exceptions: unless the Issuer has previously or concurrently delivered a redemption notice with respect to all the outstanding Notes as described under Section 5.7 SECTION 3.9. Change of Control.
    Full wording and supporting evidence
    Source evidence: (a) If a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with respect to all the outstanding Notes as described under Section 5.7 that is or has become unconditional and subject to Section 3.9(c) or under Article XI, the Issuer shall make an offer to purchase all of the Notes pursuant to the offer described below
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (f) · the Issuer may satisfy its obligations in this Section 3.10 the Issuer may satisfy its obligations in this Section 3.10 with respect to financial information relating to the Issuer by furnishing financial and other information relating to any Parent Entity instead of the Issuer; Applies to every series under this agreement (f) Notwithstanding anything to the contrary set forth in this Section 3.10
    Full wording and supporting evidence
    Source evidence: (f) Notwithstanding anything to the contrary set forth in this Section 3.10, the Issuer may satisfy its obligations in this Section 3.10 with respect to financial information relating to the Issuer by furnishing financial and other information relating to any Parent Entity instead of the Issuer;
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • SECTION 3.14. · The Issuer shall deliver to the Trustee within 120 days after the end of each fiscal year of the Issuer The Issuer shall deliver to the Trustee within 120 days after the end of each fiscal year of the Issuer Applies to every series under this agreement SECTION 3.14. Compliance Certificate.
    Full wording and supporting evidence
    Source evidence: SECTION 3.14. Compliance Certificate. The Issuer shall deliver to the Trustee within 120 days after the end of each fiscal year of the Issuer (beginning with the fiscal year ending December 31, 2025) an Officer’s Certificate, signed by the Chief Executive Officer, Chief Financial Officer or the Treasurer of the Issuer,
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • SECTION 3.16. · The Issuer shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice The Issuer shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice of any events of which it is aware which would constitute a Default or Event of Default Applies to every series under this agreement SECTION 3.16. Statement by Officers as to Default.
    Full wording and supporting evidence
    Source evidence: SECTION 3.16. Statement by Officers as to Default. The Issuer shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice of any events of which it is aware which would constitute a Default or Event of Default, their status and what action the Issuer is taking or proposes to take in respect thereof.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (d) · The Issuer shall hold quarterly conference calls for the Holders The Issuer shall hold quarterly conference calls for the Holders to discuss financial information for the previous quarter Applies to every series under this agreement (d) The Issuer shall hold quarterly conference calls for the Holders
    Full wording and supporting evidence
    Source evidence: (d) The Issuer shall hold quarterly conference calls for the Holders to discuss financial information for the previous quarter (it being understood that such quarterly conference call may be the same conference call as with Holdings’ equity investors and analysts).
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 3.10(a) · Reports the Issuer will furnish to the Trustee, within fifteen (15) days after the time periods specified below: Applies to every series under this agreement SECTION 3.10. Reports.
    Full wording and supporting evidence
    Source evidence: (a) Whether or not required by the SEC, so long as any Notes are outstanding, if not filed electronically with the SEC through the SEC’s Electronic Data Gathering, Analysis, and Retrieval System (or any successor system), from and after the Issue Date, the Issuer will furnish to the Trustee, within fifteen (15) days after the time periods specified below:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (9) · any Note Guarantee ceases to be in full force and effect, other than in accordance with the terms of this Indenture any Note Guarantee ceases to be in full force and effect, other than in accordance with the terms of this Indenture, or a Guarantor denies or disaffirms its obligations under its Note Guarantee Applies to every series under this agreement Exceptions: upon release of such Note Guarantee in accordance with this Indenture SECTION 6.1. Events of Default.
    Full wording and supporting evidence
    Source evidence: (9) any Note Guarantee ceases to be in full force and effect, other than in accordance with the terms of this Indenture, or a Guarantor denies or disaffirms its obligations under its Note Guarantee, other than in accordance with the terms thereof or upon release of such Note Guarantee in accordance with this Indenture
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (5) · default under any mortgage, indenture or instrument default under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries Applies to every series under this agreement Exceptions: other than Indebtedness owed to the Issuer or a Restricted Subsidiary SECTION 6.1. Events of Default.
    Full wording and supporting evidence
    Source evidence: (5) default under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries (or the payment of which is Guaranteed by the Issuer or any of its Restricted Subsidiaries) other than Indebtedness owed to the Issuer or a Restricted Subsidiary whether such Indebtedness or Guarantee now exists, or is created after the Issue Date, which default:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (4) · failure by the Issuer or any Guarantor to comply for 60 days after written notice failure by the Issuer or any Guarantor to comply for 60 days after written notice by the Trustee on behalf of the Holders or by the Holders of 30% in principal amount of the outstanding Notes with any other agreement or obligation Applies to every series under this agreement Exceptions: no such notice may be given with respect to any action taken, and reported publicly or to the Holders, more than two years prior to such notice SECTION 6.1. Events of Default.
    Full wording and supporting evidence
    Source evidence: (4) failure by the Issuer or any Guarantor to comply for 60 days after written notice by the Trustee on behalf of the Holders or by the Holders of 30% in principal amount of the outstanding Notes with any other agreement or obligation contained in the Notes, this Indenture or the Notes Collateral Documents; *provided* that no such notice may be given with respect to any action taken, and reported publicly or to the Holders, more than two years prior to such notice;
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (8) · failure by the Issuer or any Significant Subsidiary failure by the Issuer or any Significant Subsidiary (or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries) would constitute a Significant Subsidiary) to pay final judgments aggregating in excess of $150,000,000 Applies to every series under this agreement Metric: final judgments aggregating Stated threshold: 150000000 $ Exceptions: other than any judgments covered by indemnities provided by, or insurance policies issued by, reputable and creditworthy companies SECTION 6.1. Events of Default.
    Full wording and supporting evidence
    Source evidence: (8) failure by the Issuer or any Significant Subsidiary (or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries) would constitute a Significant Subsidiary) to pay final judgments aggregating in excess of $150,000,000 (other than any judgments covered by indemnities provided by, or insurance policies issued by, reputable and creditworthy companies), which final judgments remain unpaid, undischarged and unstayed for a period of more than 60 days after such judgment becomes final,
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (3) · failure by the Issuer or Holdings to comply with its obligations under Article IV failure by the Issuer or Holdings to comply with its obligations under Article IV; Applies to every series under this agreement SECTION 6.1. Events of Default.
    Full wording and supporting evidence
    Source evidence: (3) failure by the Issuer or Holdings to comply with its obligations under Article IV;
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (6) · Holdings, the Issuer or a Significant Subsidiary or group Holdings, the Issuer or a Significant Subsidiary or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: Applies to every series under this agreement SECTION 6.1. Events of Default.
    Full wording and supporting evidence
    Source evidence: (6) Holdings, the Issuer or a Significant Subsidiary or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • 13. Defaults and Remedies · if an Event of Default may declare the principal of and accrued and unpaid interest Applies to every series under this agreement 13. Defaults and Remedies
    Full wording and supporting evidence
    Source evidence: Except as provided otherwise in the Indenture, if an Event of Default (other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Issuer or Holdings) occurs and is continuing, the Trustee by notice to the Issuer, or the Holders of at least 30% in principal amount of the outstanding Notes by notice to the Issuer and the Trustee, may declare the principal of and accrued and unpaid interest, if any, on all the Notes to be due and payable immediately.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • SECTION 12.5. Real Property Mortgage. · shall deliver to the Collateral Agent, within 270 days after the Issue Date the Issuer shall deliver to the Collateral Agent, within 270 days after the Issue Date (or such longer period as the Collateral Agent may agree in its sole discretion) SECTION 12.5. Real Property Mortgage.
    Full wording and supporting evidence
    Source evidence: SECTION 12.5. Real Property Mortgage. The Issuer will use its commercially reasonable efforts to complete or cause to be completed on or prior to the Issue Date all filings and other similar actions required or desirable on its part in connection with the creation, perfection, protection and/or reaffirmation of such security interests in favor of the Notes and the Note Guarantees. In the case of real property constituting Mortgaged Property, the Issuer shall deliver to the Collateral Agent, within 270 days after the Issue Date (or such longer period as the Collateral Agent may agree in its sole discretion): (a) counterparts of amended or amended and restated mortgages securing the Obligations with respect to the Notes and the Note Guarantees, duly executed and delivered by the Grantor that is the record owner of each applicable Mortgaged Property and otherwise suitable for recording and in form and substance sufficient to grant to the Collateral Agent for the benefit of the Senior-Priority Non-ABL Secured Parties a valid mortgage lien on such real property; (b) title searches confirming that there are no Liens of record in violation of the applicable mortgage; (c) modification and date down endorsements to the existing title insurance policies; provided, however, with respect to the Mortgaged Properties located in Texas, a title search and T-38 endorsement, to the extent available, and, with respect to Mortgaged Properties in New Mexico, a title search and a modification endorsement; and (d) local counsel opinions, and any other documents reasonably requested by the Collateral Agent in respect of the amended or amended and restated mortgages.
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
    Target identity evidence: WHEREAS, the Issuer has duly authorized the execution and delivery of this Indenture to provide for the issuance of (i) $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Initial Notes”), each as issued on the date hereof and (ii) any additional Notes that may be issued after the Issue Date in compliance with this Indenture (the “Additional Notes” and together with the Initial Notes, the “Notes”);
  • Section 3.8(a) · Limitation on Affiliate Transactions The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, enter into or conduct any transaction Applies to every series under this agreement Metric: aggregate value Stated threshold: 40000000 $ SECTION 3.8. Limitation on Affiliate Transactions.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, enter into or conduct any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of the Issuer (an “Affiliate Transaction”) involving aggregate value in excess of $40,000,000 unless:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • (a) · create or otherwise cause or permit to exist or become effective any consensual encumbrance or consensual restriction The Issuer shall not, and shall not permit any Restricted Subsidiary that is not a Guarantor to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or consensual restriction Applies to every series under this agreement SECTION 3.4. Limitation on Restrictions on Distributions from Restricted Subsidiaries.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer shall not, and shall not permit any Restricted Subsidiary that is not a Guarantor to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or consensual restriction on the ability of any Restricted Subsidiary that is not a Guarantor to:
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • SECTION 3.13. · The Issuer shall pay or discharge or cause to be paid or discharged, before the same shall become delinquent, all material taxes The Issuer shall pay or discharge or cause to be paid or discharged, before the same shall become delinquent, all material taxes, assessments and governmental charges levied or imposed upon the Issuer or any Subsidiary; Applies to every series under this agreement SECTION 3.13. Payment of Taxes.
    Full wording and supporting evidence
    Source evidence: SECTION 3.13. Payment of Taxes. The Issuer shall pay or discharge or cause to be paid or discharged, before the same shall become delinquent, all material taxes, assessments and governmental charges levied or imposed upon the Issuer or any Subsidiary;
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • SECTION 3.12. · the Issuer will do or cause to be done all things necessary the Issuer will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence Applies to every series under this agreement SECTION 3.12. Corporate Existence.
    Full wording and supporting evidence
    Source evidence: SECTION 3.12. Corporate Existence. Except as otherwise provided in this Article III, Article IV and Section 10.2(b), the Issuer will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
  • Section 3.7(a) · Limitation on Guarantees The Issuer will not permit any of its Wholly Owned Domestic Subsidiaries that are Restricted Subsidiaries Applies to every series under this agreement SECTION 3.7. Limitation on Guarantees.
    Full wording and supporting evidence
    Source evidence: (a) The Issuer will not permit any of its Wholly Owned Domestic Subsidiaries that are Restricted Subsidiaries
    Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
Documents and filing history
  1. Issuance · 2025-08-12 Original principal USD 1,790,000,000 Exact source document Parent 8-K filing · 2025-08-12
    WHEREAS, each of the Issuer, the Guarantors, the Trustee and the Collateral Agent have heretofore executed and delivered an indenture dated as of August 12, 2025 (as amended, supplemented, waived or otherwise modified, the “Indenture”), providing for the issuance on such date of an aggregate principal amount of $1,790,000,000 of 9.750% Senior Secured Notes due 2034 (the “Notes”) of the Issuer;
    Issuer evidence: SUPPLEMENTAL INDENTURE, (this “Supplemental Indenture”) dated as of [ ], 20[ ], by and among CHS/Community Health Systems, Inc., a Delaware corporation (“Issuer”), the parties that are signatories hereto as Guarantors (each, a “Guaranteeing Subsidiary”) and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent under the Indenture referred to below.
    Supporting evidence: WHEREAS, each of the Issuer, the Guarantors, the Trustee and the Collateral Agent have heretofore executed and delivered an indenture dated as of August 12, 2025 (as amended, supplemented, waived or otherwise modified, the “Indenture”), providing for the issuance on such date of an aggregate principal amount of $1,790,000,000 of 9.750% Senior Secured Notes due 2034 (the “Notes”) of the Issuer;
  2. Issuance · 2025-08-12 Original principal USD 1,790,000,000 Exact source document Parent 8-K filing · 2025-08-12
    On August 12, 2025, CHS/Community Health Systems, Inc. (the “Issuer”), a direct, wholly owned subsidiary of Community Health Systems, Inc. (the “Company”), completed its previously announced offering (the “Notes Offering”) of $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Notes”). The terms of the Notes are governed by an indenture, dated as of August 12, 2025, among the Issuer, the Company, the subsidiary guarantors party thereto, U.S. Bank Trust Company, National Association, as trustee and as collateral agent (the “Collateral Agent”) (the “Indenture”).
    Issuer evidence: On August 12, 2025, CHS/Community Health Systems, Inc. (the “Issuer”), a direct, wholly owned subsidiary of Community Health Systems, Inc. (the “Company”), completed its previously announced offering (the “Notes Offering”) of $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Notes”). The terms of the Notes are governed by an indenture, dated as of August 12, 2025, among the Issuer, the Company, the subsidiary guarantors party thereto, U.S. Bank Trust Company, National Association, as trustee and as collateral agent (the “Collateral Agent”) (the “Indenture”).
    Supporting evidence: The Notes bear interest at a rate of 9.750% per year payable semi-annually in arrears on March 15 and September 15 of each year (and January 15, 2034, the maturity date), commencing on March 15, 2026.
    Supporting evidence: On August 12, 2025, CHS/Community Health Systems, Inc. (the “Issuer”), a direct, wholly owned subsidiary of Community Health Systems, Inc. (the “Company”), completed its previously announced offering (the “Notes Offering”) of $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Notes”). The terms of the Notes are governed by an indenture, dated as of August 12, 2025, among the Issuer, the Company, the subsidiary guarantors party thereto, U.S. Bank Trust Company, National Association, as trustee and as collateral agent (the “Collateral Agent”) (the “Indenture”).

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
0.83×
Peer median 0.96×
EV/EBIT
7.64×
Peer median 20.33×
P/E (TTM)
6.00×
Peer median 23.70×
Price/Sales (TTM)
0.02×
Peer median 0.96×
Price/Book
—
Peer median 2.24×

Peer medians compare against the 23 similar-size Medical Care Facilities companies (of 58 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Managed Care and Other Third Party Payors $5,975,000,000 $6,078,000,000 $5,978,000,000 $5,806,000,000 $6,076,000,000 — $8,014,000,000 $8,349,000,000
Medicare Managed Care $2,251,000,000 $2,242,000,000 $2,103,000,000 $1,968,000,000 $1,861,000,000 $1,601,000,000 — —
Medicare $2,172,000,000 $2,282,000,000 $2,484,000,000 $2,547,000,000 $2,650,000,000 $2,813,000,000 $3,331,000,000 $3,730,000,000
Medicaid $1,991,000,000 $1,870,000,000 $1,790,000,000 $1,807,000,000 $1,671,000,000 $1,578,000,000 $1,736,000,000 $1,876,000,000
Self Pay Revenue $96,000,000 $162,000,000 $135,000,000 $83,000,000 $110,000,000 -$2,000,000 $129,000,000 $200,000,000
Other Third Party Payors — — — — — $5,799,000,000 — —
Key facts CIK 1108109 CUSIP 203668108 13F (30d) 172 filings 156 filers Visit website Investor relations